Gemcitabine (Ebewe) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: vutrisiran
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 200 mg/20 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
GEMCITABINE SANDOZ is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (NSCLC). - locally advanced or metastatic adenocarcinoma of the pancreas . - Fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous
- Clear colourless solution in a clear glass vial with a grey rubber stopper
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 20mL vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 1000 mg/100 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
GEMCITABINE SANDOZ is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (NSCLC). - locally advanced or metastatic adenocarcinoma of the pancreas . - Fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous
- Clear colourless solution in a clear glass vial with a grey rubber stopper
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 100mL vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 500 mg/50 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
GEMCITABINE SANDOZ is indicated for treatment of patients with:. - locally advanced or metastatic non-small cell lung cancer (NSCLC). - locally advanced or metastatic adenocarcinoma of the pancreas . - Fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.. - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous
- Clear colourless solution in a clear glass vial with a grey rubber stopper
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 50mL vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 1000 mg/25 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
? Treatment of patients with locally advanced or metastatic non-small cell lung cancer. ? Treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. ? Treatment of patients with 5FU refractory pancreatic cancer. ? Treatment of patients with bladder cancer, alone or in combination with cisplatin. ? Treatment, in combination with paclitaxel, of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. ? Treatment, in combination with carboplatin, of patients with recurrent epithelial ovarian carcinoma, who have relapsed > six months following platinum based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- clear, colorless to pale yellow solution for injection
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 200 mg/5 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
Treatment of patients with locally advanced or metastatic non-small cell lung cancer. ? Treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. ? Treatment of patients with 5FU refractory pancreatic cancer. ? Treatment of patients with bladder cancer, alone or in combination with cisplatin. ? Treatment, in combination with paclitaxel, of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. ? Treatment, in combination with carboplatin, of patients with recurrent epithelial ovarian carcinoma, who have relapsed > six months following platinum based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- clear, colorless to pale yellow solution for injection
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE SANDOZ gemcitabine (as hydrochloride) 2000 mg/50 mL concentrated solution for infusion vialWhat this medicine is used for
(ARTG)
Treatment of patients with locally advanced or metastatic non-small cell lung cancer. ? Treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. ? Treatment of patients with 5FU refractory pancreatic cancer. ? Treatment of patients with bladder cancer, alone or in combination with cisplatin. ? Treatment, in combination with paclitaxel, of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. ? Treatment, in combination with carboplatin, of patients with recurrent epithelial ovarian carcinoma, who have relapsed > six months following platinum based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous Infusion
- clear, colorless to pale yellow solution for injection
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE EBEWE gemcitabine (as hydrochloride) 1000 mg powder for injection vialWhat this medicine is used for
(ARTG)
Gemcitabine Ebewe is indicated for treatment of patients with: . - locally advanced or metastatic non-small cell lung cancer (NSCLC) . - locally advanced or metastatic adenocarcinoma of the pancreas. - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. . - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. . - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous Infusion
- White or almost white compact aggregate in a 50mL clear glass vial with a halobutyl rubber stopper. Packed in a cardboard carton.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 50 mL vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE EBEWE gemcitabine (as hydrochloride) 200 mg powder for injection vialWhat this medicine is used for
(ARTG)
Gemcitabine Ebewe is indicated for treatment of patients with: . - locally advanced or metastatic non-small cell lung cancer (NSCLC) . - locally advanced or metastatic adenocarcinoma of the pancreas. - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. . - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. . - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous Infusion
- White or almost white compact aggregate in a 10mL clear glass vial with a halobutyl rubber stopper. Packed in a cardboard carton.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 10 mL vial pack
- 5 x 10 mL vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: GEMCITABINE EBEWE gemcitabine (as hydrochloride) 200 mg powder for injection vialWhat this medicine is used for
(ARTG)
Gemcitabine Ebewe is indicated for treatment of patients with: . - locally advanced or metastatic non-small cell lung cancer (NSCLC) . - locally advanced or metastatic adenocarcinoma of the pancreas. - fluorouracil refractory pancreatic cancer. - (alone or in combination with cisplatin) bladder cancer. . - (in combination with paclitaxel) unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. . - (in combination with carboplatin) recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum-based therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous Infusion
- White or almost white compact aggregate in a 10mL clear glass vial with a halobutyl rubber stopper. Packed in a cardboard carton.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 1 x 10 mL vial pack
- 5 x 10 mL vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
